Treatment of Familial Benign Chronic Pemphigus With Superficial Radiotherapy.
Sign Up to like & getrecommendations! Published in 2022 at "JAMA dermatology"
DOI: 10.1001/jamadermatol.2021.5491
Abstract: Importance Hailey-Hailey disease (HHD) is a chronic genodermatosis with recurrent vesicles and erosions mainly in the intertriginous areas. Hailey-Hailey disease severely affects patient quality of life. Standard treatments attempt to control the flares, but often… read more here.
Keywords: long term; cycle; remission; superficial radiotherapy ... See more keywords
Ketamine vs Electroconvulsive Therapy for Major Depressive Episode: A Systematic Review and Meta-analysis.
Sign Up to like & getrecommendations! Published in 2023 at "JAMA psychiatry"
DOI: 10.1001/jamapsychiatry.2023.0562
Abstract: Importance The relative efficacy of ketamine and electroconvulsive therapy (ECT) in adults with major depressive episode (MDE) needs clarification. Objective To compare depression rating outcomes with ketamine vs ECT in adults with MDE and to… read more here.
Keywords: response remission; remission; number; meta ... See more keywords
Certolizumab pegol for induction of remission in Crohn's disease
Sign Up to like & getrecommendations! Published in 2017 at "Cochrane Database of Systematic Reviews"
DOI: 10.1002/14651858.cd012893
Abstract: BACKGROUND Crohn's disease (CD) is a chronic inflammatory disease of the gastrointestinal tract, and immune response modulation is the main treatment strategy to induce remission in active CD. Certolizumab pegol (CZP) is a tumor necrosis… read more here.
Keywords: week; response; remission; placebo ... See more keywords
Significance of recurrence of minimal residual disease detected by multi‐parameter flow cytometry in patients with acute lymphoblastic leukemia in morphological remission
Sign Up to like & getrecommendations! Published in 2017 at "American Journal of Hematology"
DOI: 10.1002/ajh.24629
Abstract: We sought to determine the significance of minimal residual disease (MRD) relapse in patients with ALL after achieving MRD negative status following induction and consolidation therapy. Between January 2003 and September 2014, 647 newly diagnosed… read more here.
Keywords: multi parameter; minimal residual; recurrence; remission ... See more keywords
Haploidentical vs matched unrelated donor transplantation for acute myeloid leukemia in remission: A prospective comparative study
Sign Up to like & getrecommendations! Published in 2020 at "American Journal of Hematology"
DOI: 10.1002/ajh.25993
Abstract: Despite comparable outcomes of haploidentical transplants (Haplo‐HSCT) with HLA‐matched unrelated transplants (MUD‐HSCT) in retrospective comparisons, few studies have prospectively compared Haplo‐HSCT with MUD‐HSCT in AML. Here, we prospectively compared the outcomes of Haplo‐HSCT with MUD‐HSCT… read more here.
Keywords: haplo hsct; mud hsct; remission; hsct ... See more keywords
Clinical outcomes and impact of therapeutic intervention in patients with acute myeloid leukemia who experience measurable residual disease (MRD) recurrence following MRD‐negative remission
Sign Up to like & getrecommendations! Published in 2022 at "American Journal of Hematology"
DOI: 10.1002/ajh.26698
Abstract: neoplastic that in remission using techniques that are more than conventional cytomorphological assessment. 2,3 Persistent MRD after leukemia-directed therapy powerful in read more here.
Keywords: clinical outcomes; impact therapeutic; remission; leukemia ... See more keywords
Pharmacogenomic Testing and Depressive Symptom Remission: A Systematic Review and Meta‐Analysis of Prospective, Controlled Clinical Trials
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Pharmacology and Therapeutics"
DOI: 10.1002/cpt.2748
Abstract: Pharmacogenomic (PGx) testing has emerged as a compelling strategy that clinicians can use to inform antidepressant medication selection and dosing, but the clinical efficacy of this strategy has been questioned. We systematically reviewed and meta‐analyzed… read more here.
Keywords: clinical trials; depressive symptom; remission; symptom remission ... See more keywords
Rates of remission, sustained remission, and recurrence in a randomized controlled trial of cognitive behavioral therapy versus supportive psychotherapy for body dysmorphic disorder.
Sign Up to like & getrecommendations! Published in 2021 at "Depression and anxiety"
DOI: 10.1002/da.23148
Abstract: BACKGROUND Little data exist on remission rates following psychotherapy for body dysmorphic disorder (BDD). METHODS Using data from a large study of therapist-delivered cognitive behavior therapy (CBT) versus supportive psychotherapy (SPT) for BDD (N = 120), we… read more here.
Keywords: spt; sustained remission; cbt spt; remission ... See more keywords
Leveraging smart technologies to improve the management of diabetic foot ulcers and extend ulcer‐free days in remission
Sign Up to like & getrecommendations! Published in 2020 at "Diabetes/Metabolism Research and Reviews"
DOI: 10.1002/dmrr.3239
Abstract: The prevalent and long neglected diabetic foot ulcer (DFU) and its related complications rank among the most debilitating and costly sequelae of diabetes. Management of the DFU is multifaceted and requires constant monitoring from patients,… read more here.
Keywords: ulcer free; remission; free days; management ... See more keywords
Automatic auditory processing features in distinct subtypes of patients at clinical high risk for psychosis: Forecasting remission with mismatch negativity
Sign Up to like & getrecommendations! Published in 2022 at "Human Brain Mapping"
DOI: 10.1002/hbm.26021
Abstract: Individuals at clinical high risk (CHR) for psychosis exhibit a compromised mismatch negativity (MMN) response, which indicates dysfunction of pre‐attentive deviance processing. Event‐related potential and time‐frequency (TF) information, in combination with clinical and cognitive profiles,… read more here.
Keywords: processing; frequency; high risk; remission ... See more keywords
AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST REMISSION SIGNIFICANTLY PROLONGS PROGRESSION‐FREE AND OVERALL SURVIVAL IN MANTLE CELL LYMPHOMA
Sign Up to like & getrecommendations! Published in 2019 at "Hematological Oncology"
DOI: 10.1002/hon.13_2629
Abstract: Introduction: Ibrutinib with rituximab (IR) combination induces durable responses in relapsed MCL. This is a single institution phase II trial of IR with short course (4 cycles) of R-HCVAD/R-MTX consolidation as frontline therapy in MCL.… read more here.
Keywords: part; stem cell; response; cell ... See more keywords